Investor Relations

Enhancing shareholder value through exceptional business performance and practices, and through responsible and effective communication with its shareholders.

Investor relations

Media Coverage

May 7, 2020

Hoth Therapeutics, Inc. (NasdaqCM: HOTH) Targeting The $7 Billion Dermatological Disorders Market With BioLexa Platform

Seeking Alpha
Apr 9, 2020

Global Dermatologicals Market Is Expected To Reach $36.2 Billion By 2026

Financial News Media
Apr 7, 2020

See what it takes to make a vaccine during the coronavirus pandemic

The Hill
Apr 6, 2020

Researchers harness new technology for rapid COVID-19 vaccine development

Fierce Biotech
Mar 24, 2020

Hoth Surges on Collaboration With Voltron for COVID-19 Vaccine

Yahoo! Finance
Mar 23, 2020

‘It’s an incredibly challenging time’: Hoth, Voltron form Halovax to find COVID-19 vaccine

BioWorld
Feb 7, 2020

Developing the Next Generation of Drugs for Dermatological Conditions

Technology Networks Group